Skip to main content

Be confident that your patient care is up to date

Register now and start receiving our tailored medical education content from April. You can also secure your place for the first live webinar.

IN FOCUS | Genitourinary cancers

Senior man holding bottle with pills and taking medicine with glass of water

14-02-2023 | Prostate cancer | News

Maintenance darolutamide shows promise in metastatic CRPC

Phase 2 data point to the potential of switch maintenance with darolutamide in men with metastatic castration-resistant prostate cancer that has not progressed after taxane therapy.

IN FOCUS | Lung & thoracic cancers

DNA mutation

28-10-2022 | Non-small-cell lung cancer | News

Real-world study adds support for osimertinib for uncommon EGFR mutations

Osimertinib elicits high rates of systemic and intracranial response in people with advanced non-small-cell lung cancer harboring uncommon EGFR mutations, say the authors of the real-world UNICORN study.

IN FOCUS | Breast cancer

Doctor with clipboard and senior woman in consultation

01-03-2023 | Breast cancer | News

PRIME II ‘extremely reassuring’ on radiotherapy omission in older women with early breast cancer

The 10-year data from the PRIME II trial suggest that radiotherapy after breast-conserving surgery can be omitted for women aged 65 years or older with low-risk, hormone receptor-positive early breast cancer.

IN FOCUS | COVID-19 & cancer

Antibodies attacking SARS-CoV-2 virus, the conceptual 3D illustration for COVID-19 treatment, diagnosis and prevention

10-01-2023 | COVID-19 | News

Antibody testing may identify cancer patients at increased risk of COVID-19 breakthrough infections

A Canadian population-based study has confirmed that people with cancer have an increased risk of breakthrough COVID-19 infection after vaccination, while UK research points to the feasibility of SARS-CoV-2 antibody testing to identify those with the lowest level of vaccine-derived protection.

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox